Best Integrated Utility Companies To Watch In Right Now

Check out Jim Cramer's latest trading recommendations on "Action Alerts Plus".

(Updates from 10:48 a.m. ET with closing information.)

NEW YORK (TheStreet) -- Here's what Jim Cramer had to say on CNBC's "Squawk on the Street" Tuesday.

Citigroup says to buy FedEx (FDX) ahead of its earnings report next week. Cramer disagreed, saying United Parcel Service (UPS) "is cheaper." FDX was off 1% to $138.49.

It will be a great 2014 for PVH Corp. (PVH), Cramer said. He said investors should own PVH at these levels, not sell it. PVH was 3.5% higher to $131.87.

Twitter (TWTR) is making new highs and Bernstein says advertisers love the platform. Cramer equated shorting the stock to investment suicide. TWTR flew 5.8% higher to $51.99.

Hot US Companies To Invest In 2015: Ziggo NV (ZIGGO)

Ziggo NV is the Netherlands-based provider of entertainment, information and communication through television, Internet and telephony services. The Company provides digital, interactive and high definition (HD) television, broadband Internet, data communication and telephony services to both private and corporate customers. To business customers, it offers services over the network. For home use and small business, they are provided through business bundles and packages, such as Office Basis, Internet Plus and All-in-1. Ziggo NV serves around 3 million households, with almost 1.8 million Internet subscribers, more than 2.2 million subscribers using digital television and about 1.4 million telephony subscribers. Additionally, it operates a music streaming service, Ziggo Muziek, and a fiber optic network. The Company is wholly owned by Zesko Holding BV and has several subsidiaries, such as Zesko BV, Ziggo Bond Company Holding BV and Ziggo Bond Company BV, among others. Advisors' Opinion:

• [By Sarah Jones]

  Ziggo NV (ZIGGO), a Dutch cable-television operator, advanced 4.5 percent to 29.58 euros, after Vodafone confirmed it approached Kabel Deutschland. Liberty Global Inc., which owns an 18 percent stake in Ziggo, had also considered bidding for the German company, two people familiar with the matter said in April.

Best Integrated Utility Companies To Watch In Right Now: Sturm Ruger & Company Inc. (RGR)

Sturm, Ruger & Company, Inc. engages in the design, manufacture, and sale of firearms in the United States. The company offers its products under the ?Ruger? name and trademark in four product categories, including single-shot, autoloading, bolt-action, and sporting rifles; over and under shotguns; rimfire autoloading and centerfire autoloading pistols; and single action and double action revolvers. It also manufactures and sells accessories and replacement parts for its firearms. In addition, the company produces and sells investment castings made from steel alloys. Sturm, Ruger & Company, Inc. sells its firearms through a network of selected licensed independent wholesale distributors; and markets investment castings through manufacturer?s representatives to commercial, sporting goods, and military sectors. The company was founded in 1948 and is based in Southport, Connecticut.

Advisors' Opinion:

• [By Aaron Smith]

  Shares for rival gunmaker Sturm Ruger (RGR) dipped slightly on Friday. But the performance year-to-date for gun stocks has been outstanding, with Sturm Ruger jumping 21% and Smith & Wesson surging 36%.

Best Integrated Utility Companies To Watch In Right Now: Tonix Pharmaceuticals Holding Corp (TNXP)

Tonix Pharmaceuticals Holding Corp., incorporated on November 16, 2011, is a specialty pharmaceutical company focused on developing novel pharmaceutical products for disorders of the central nervous system (CNS). The Company develops TNX-102 sublingual tablet, or TNX-102 SL. TNX-102 SL is a novel dose and formulation of cyclobenzaprine (CBP), the active pharmaceutical ingredient of two prescribed muscle relaxant products, Flexeril and Amrix. TNX-102 SL is also intended for chronic use. It develops TNX-102 SL for the treatment of FM under a United States Investigational New Drug application (IND), and under three clinical trial applications (CTAs), filed in Canada. It also develops TNX-102 SL for the treatment of post-traumatic stress disorder (PTSD). As of January 25, 2013, the Company focuses on product development, and had not generated any revenues.

The Company searches for potential therapeutic solutions among known pharmaceutical agents that lack regulatory approval for the indications it seeks, but may be approved for use in other indications. It seeks to create new dose and formulation options that are tailored to the therapeutic uses to which it applies these agents. TNX-102 SL is a small, rapidly disintegrating tablet containing CBP for sublingual administration at bedtime. The Company designed TNX-102 SL for delivery of CBP to the systemic circulation through sublingual transmucosal absorption and to avoid first-pass liver metabolism.

CBP is the active pharmaceutical ingredient in its lead product candidate, TNX-102 SL. In addition to CBP, TNX-102 SL contains inactive ingredients, called excipients, which are approved for pharmaceutical use. In addition to TNX-102 SL, it develops other formulations of CBP, including TNX-102 promicellar gelatin capsule, or TNX-102 gelcap. It developed TNX-102 gelcap under an agreement with Lipocine, Inc. (Lipocine), a contract formulation developer and small-scale manufacturer. In addition it has other pipeline of other product cand! idates, including TNX-201 and TNX-301. TNX-201 is based on isometheptene mucate and is under development as a treatment for certain types of headaches.

Advisors' Opinion:

• [By John Kell]

  Tonix Pharmaceuticals Holding Corp.(TNXP) is planning to offer some shares to raise money to fund clinical trials and the continued development of the specialty pharmaceutical company’s treatments. Shares edged up 2.1% to $16.75 premarket.

• [By John Udovich]

  It�� a new year and the first one and a half trading weeks of 2014 has not disappointed biotech investors as the sector and mid cap or small cap biotech or�pharma stocks like Intercept Pharmaceuticals Inc (NASDAQ: ICPT), Epizyme Inc (NASDAQ: EPZM), Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) and TNI BioTech Inc (OTCQB: TNIB) either surging or producing some news plus there have been IPO filings for future listings for�Flexion Therapeutics (NASDAQ: FLXN), Aldexa Therapeutics (NASDAQ: ALDX), Retrophin (NASDAQ:�RTRX) and Dicerna Pharmaceuticals (NASDAQ: DRNA). Consider the following news so far this year:

Best Integrated Utility Companies To Watch In Right Now: Horizon Technology Finance Corporation (HRZN)

Horizon Technology Finance Corporation, a specialty finance company, lends to and invests in development-stage companies in the United States. It provides secured loans to companies backed by established venture capital and private equity firms in the technology, life science, healthcare information and services, and cleantech industries. Horizon Technology Finance Corporation was founded in 2008 and is based in Farmington, Connecticut.

Advisors' Opinion:

• [By BDC Buzz]

  I believe investors should look past the current low dividend yields and relatively higher multiples of NAV per share for BDCs such as FDUS, MAIN, and TCAP, but should consider the total return for these companies. The table below compares FDUS and MAIN to both ACAS which does not pay dividends and Horizon Technology Finance (HRZN) that pays a higher than average dividend but after taking into account dividend growth, special dividends, and NAV per share growth (using last twelve months actual for projection purposes) it is clear that the expected investor return is based on more than the current dividend yield.